D-livering the message: The importance of vitamin D status in chronic liver disease

Journal of Hepatology

Volumn 57, Issue 4, 2012, Pages 897-909

  Kitson, Matthew T ^a   Roberts, Stuart K ^a  

^a Alfred ^*  (Australia)

Author keywords

Cholecalciferol; Liver disease; Liver fibrosis; Vitamin D

Indexed keywords

VITAMIN D; VITAMIN D RECEPTOR;

ADAPTIVE IMMUNITY; CHRONIC LIVER DISEASE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEPATITIS C; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYNTHESIS; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

ADAPTIVE IMMUNITY; CHRONIC DISEASE; FATTY LIVER; GENOME-WIDE ASSOCIATION STUDY; HEPATITIS C, CHRONIC; HUMANS; IMMUNITY, INNATE; LIVER CIRRHOSIS; LIVER DISEASES; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84866382064     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.033     Document Type: Review

References (148)

1. M.F. Holick, and M. Garabedian Vitamin D: photobiology, metabolism, mechanism of action, and clinical applications M.J. Favus, Primer on the metabolic bone diseases and disorders of mineral metabolism 6th ed. 2006 American Society for Bone and Mineral Research Washington, DC 129 137
2. P. White, and N. Cooke The multifunctional properties and characteristics of vitamin D-binding protein Trends Endocrinol Metab 11 2000 320 327
3. M.I. Kamboh, and R.E. Ferrell Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations Hum Genet 72 1986 281 293
4. N. Yamamoto, and S. Homma Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes Proc Natl Acad Sci U S A 88 1991 8539 8543
5. J.P. Metcalf, A.B. Thompson, G.L. Gossman, K.J. Nelson, S. Koyama, and S.I. Rennard Gc globulin functions as a cochemotaxin in the lower respiratory tract. A potential mechanism for lung neutrophil recruitment in cigarette smokers Am Rev Respir Dis 143 1991 844 849
6. M.F. Holick, and D. Vitamin Deficiency N Engl J Med 357 2007 266 281
7. R. Bouillon, G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, and H.F. Luderer Vitamin D and human health: lessons from vitamin D receptor null mice Endocr Rev 29 2008 726 776
8. M.F. Holick High prevalence of vitamin D inadequacy and implications for health Mayo Clin Proc 81 2006 353 373
9. H.A. Bischoff-Ferrari, E. Giovannucci, W.C. Willett, T. Dietrich, and B. Dawson-Hughes Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes Am J Clin Nutr 84 2006 18 28
10. A. Malabanan, I.E. Veronikis, and M.F. Holick Redefining vitamin D insufficiency Lancet 351 1998 805 806
11. B. Dawson-Hughes, R.P. Heaney, M.F. Holick, P. Lips, P.J. Meunier, and R. Vieth Estimates of optimal vitamin D status Osteoporos Int 16 2005 713 716
12. R. Bouillon Genetic and environmental determinants of vitamin D status Lancet 376 2010 148 149
13. M.C. Chapuy, P. Preziosi, M. Maamer, S. Arnaud, P. Galan, and S. Hercberg Prevalence of vitamin D insufficiency in an adult normal population Osteoporos Int 7 1997 439 443
14. V. Tangpricha, E.N. Pearce, T.C. Chen, and M.F. Holick Vitamin D insufficiency among free-living healthy young adults Am J Med 112 2002 659 662
15. J.J. McGrath, M.G. Kimlin, S. Saha, D.W. Eyles, and A.V. Parisi Vitamin D insufficiency in south-east Queensland Med J Aust 174 2001 150 151
16. P. Autier, and S. Gandini Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials Arch Intern Med 167 2007 1730 1737
17. L. Fisher, and A. Fisher Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease Clin Gastroenterol Hepatol 5 2007 513 520
18. J. Arteh, S. Narra, and S. Nair Prevalence of vitamin D deficiency in chronic liver disease Dig Dis Sci 55 2010 2624 2628
19. Reese PP, Bloom RD, Feldman HI, Huverserian A, Thomasson A, Shults J, et al. Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int 2011 Sep 9. doi: http://dx.doi.org/10. 1111/j.1478-3231.2011.02638.x. [Epub ahead of print].
20. A. Rode, S. Fourlanos, and A. Nicoll Oral vitamin D replacement is effective in chronic liver disease Gastroenterol Clin Biol 34 2010 618 620
21. M. Malham, S.P. Jorgensen, P. Ott, J. Agnholt, H. Vilstrup, and M. Borre Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than Aetiology World J Gastroenterol 17 2011 922 925
22. J.G. Heaf Hepatic osteodystrophy Scand J Gastroenterol 20 1985 1035 1040
23. J.E. Compston Hepatic osteodystrophy: vitamin D metabolism in patients with liver disease Gut 27 1986 1073 1090
24. S. Masuda, T. Okano, K. Osawa, M. Shinjo, T. Suematsu, and T. Kobayashi Concentrations of vitamin D-binding protein and vitamin D metabolites in plasma of patients with liver cirrhosis J Nutr Sci Vitaminol (Tokyo) 35 1989 225 234
25. F.V. Schiodt Gc-globulin in liver disease Dan Med Bull 55 2008 131 146
26. o164. http://www.who.int/mediacentre/factsheets/fs164/en/.
27. C.W. Shepard, L. Finelli, and M.J. Alter Global epidemiology of hepatitis C virus infection Lancet Infect Dis 5 2005 558 567
28. S. Petta, C. Cammà, C. Scazzone, C. Tripodo, V. Di Marco, and A. Bono Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C Hepatology 51 2010 1158 1167
29. C.M. Lange, J. Bojunga, E. Ramos-Lopez, M. von Wagner, A. Hassler, and J. Vermehren Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy J Hepatol 54 2011 887 893
30. M. Gal-Tanamy, L. Bachmetov, A. Ravid, R. Koren, A. Erman, and R. Tur-Kaspa Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes Hepatology 54 2011 1570 1579
31. T. Matsumura, T. Kato, M. Tasaka-Fujita, A. Murayama, T. Masaki, and T. Wakita 25-hydroxyvitamin D inhibits hepatitis C virus replication and production of the infectious viruses Hepatology 54 2011 S547A
32. M. Yano, M. Ikeda, K. Abe, H. Dansako, S. Ohkoshi, and Y. Aoyagi Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture Antimicrob Agents Chemother 51 2007 2016 2027
33. D. Bitetto, G. Fattovich, C. Fabris, E. Ceriani, E. Falleti, and E. Fornasiere Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C Hepatology 53 2011 1118 1126
34. B. Terrier, F. Carrat, G. Geri, S. Pol, L. Piroth, and P. Halfon Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis J Hepatol 55 2011 756 761
35. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 2009 399 401
36. S. Abu-Mouch, Z. Fireman, J. Jarchovsky, A.R. Zeina, and N. Assy Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients World J Gastroenterol 17 2011 5184 5190
37. A. Nimer, and A. Mouch Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients World J Gastroenterol 18 2012 800 805
38. D. Bitetto, C. Fabris, E. Fornasiere, C. Pipan, E. Fumolo, and A. Cussigh Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C Transpl Int 24 2011 43 50
39. Baur K, Mertens JC, Schmitt J, Iwata R, Stieger B, Eloranta JJ, et al. Combined effect of 25-OH vitamin D plasma levels and genetic Vitamin D Receptor (NR 1|1) variants on fibrosis progression rate in HCV patients. Liver Int 2011 Dec 8. doi: http://dx.doi.org/10.1111/j.1478-3231.2011.02674.x. [Epub ahead of print].
40. K. Patel, J.E. Lucas, J.W. Thompson, L.G. Dubois, H.L. Tillmann, and A.J. Thompson High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients Hepatology 53 2011 1809 1818
41. A.S. Ho, C.C. Cheng, S.C. Lee, M.L. Liu, J.Y. Lee, and W.M. Wang Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein A1 J Biomed Sci 17 2010 58
42. O.A. Gressner, C. Gao, M. Siluschek, P. Kim, and A.M. Gressner Inverse association between serum concentrations of actin-free vitamin D-binding protein and the histopathological extent of fibrogenic liver disease or hepatocellular carcinoma Eur J Gastroenterol Hepatol 21 2009 990 995
43. M. Lazo, R. Hernaez, S. Bonekamp, I.R. Kamel, F.L. Brancati, and E. Guallar Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study BMJ 343 2011 d6891 10.1136/bmj.d6891
44. C.D. Williams, J. Stengel, M.I. Asike, D.M. Torres, J. Shaw, and M. Contreras Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study Gastroenterology 140 2011 124 131
45. K. Promrat, D.E. Kleiner, H.M. Niemeier, E. Jackvony, M. Kearns, and J.R. Wands Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis Hepatology 51 2010 121 129
46. E.M. Stein, G. Strain, N. Sinha, D. Ortiz, A. Pomp, and G. Dakin Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study Clin Endocrinol (Oxf) 71 2009 176 183
47. E. Hyppönen, B.J. Boucher, D.J. Berry, and C. Power 25-hydroxy vitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort Diabetes 57 2008 298 305
48. E. Liu, J.B. Meigs, A.G. Pittas, N.M. McKeown, C.D. Economos, and S.L. Booth Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults J Nutr 139 2009 329 334
49. N.G. Forouhi, J. Luan, A. Cooper, B.J. Boucher, and N.J. Wareham Baseline serum 25-hydroxyvitamin D is predictive of future glycaemic status and insulin resistance. the Medical Research Council Ely Prospective Study 1990-2000 Diabetes 57 2008 2619 2625
50. A.G. Pittas, J. Lau, F.B. Hu, and B. Dawson-Hughes The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis J Clin Endocrinol Metab 92 2007 2017 2029
51. K.C. Chiu, A. Chu, V.L. Go, and M.F. Saad Hypovitaminosis D is associated with insulin resistance and β cell dysfunction Am J Clin Nutr 79 2004 820 825
52. J. Nagpal, J.N. Pande, and A. Bhartia A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men Diabet Med 26 2009 19 27
53. P.R. von Hurst, W. Stonehouse, and J. Coad Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial Br J Nutr 103 2010 549 555
54. A.G. Pittas, B. Dawson-Hughes, T. Li, R.M. Van Dam, W.C. Willett, and J.E. Manson Vitamin D and calcium intake in relation to type 2 diabetes in women Diabetes Care 29 2006 650 656
55. G. Targher, L. Bertolini, L. Scala, M. Cigolini, L. Zenari, and G. Falezza Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease Nutr Metab Cardiovasc Dis 17 2007 517 524
56. I. Barchetta, F. Angelico, M. Del Ben, M.G. Baroni, P. Pozzilli, and S. Morini Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes BMC Med 9 2011 85
57. M. Manco, P. Ciampalini, and V. Nobili Low levels of 25-hydroxyvitamin D3 in children with biopsy-proven nonalcoholic fatty liver disease Hepatology 51 2010 2229
58. T. Nakano, Y.F. Cheng, C.Y. Lai, L.W. Hsu, Y.C. Chang, and J.Y. Deng Impact of artificial sunlight therapy on the progress of non-alcoholic fatty liver disease in rats J Hepatol 55 2011 415 425
59. Roth CL, Elfers CT, Figlewicz DP, Melhorn SJ, Morton GJ, Hoofnagle A, et al. Vitamin D deficiency in obese rats exacerbates NAFLD and increases hepatic resistin and toll-like receptor activation. Hepatology 2011 Oct 12. doi: http://dx.doi.org/10.1002/hep.24737. [Epub ahead of print].
60. A.M. Ramirez, C. Wongtrakool, T. Welch, A. Steinmeyer, U. Zügel, and J. Roman Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells J Steroid Biochem Mol Biol 118 2010 142 150
61. J.N. Artaza, and J.C. Norris Vitamin D reduces the expression of collagen and key profibrotic factors by inducing an antifibrotic phenotype in mesenchymal multipotent cells J Endocrinol 200 2009 207 221
62. S. Abramovitch, L. Dahan-Bachar, E. Sharvit, Y. Weisman, A.B. Tov, and E. Brazowski Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats Gut 60 2011 1728 1737
63. S. Reif, A. Betov, E. Sharvit, E. Brazowski, Y. Weisman, and S. Abramovitch Vitamin D has a protective antifibrotic effect in rat model of liver fibrosis Hepatology 54 2011 S747A
64. L. Fan, X. Tu, Y. Zhu, L. Zhou, T. Pfeiffer, and R. Feltens Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese J Gastroenterol Hepatol 20 2005 249 255
65. L. Adorini, and D. Vitamin Receptor polymorphisms in primary biliary cirrhosis: a functional connection? J Hepatol 50 2009 1071 1073
66. E. Falleti, D. Bitetto, C. Fabris, A. Cussigh, E. Fontanini, and E. Fornasiere Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis World J Gastroenterol 16 2010 3016 3024
67. Y.W. Huang, Y.T. Liao, W. Chen, C.L. Chen, J.T. Hu, and C.J. Liu Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan Genes Immun 11 2010 87 93
68. P.V. Suneetha, S.K. Sarin, A. Goyal, G.T. Kumar, D.K. Shukla, and S. Hissar Association between vitamin D receptor, CCR5, TNF-α and TNF-β gene polymorphisms and HBV infection and severity of liver disease J Hepatol 44 2006 856 863
69. R. Bellamy, C. Ruwende, T. Corrah, K.P. McAdam, M. Thursz, and H.C. Whittle Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene J Infect Dis 179 1999 721 724
70. M.K. Arababadi, A.A. Pourfathollah, A. Jafarzadeh, G. Hassanshahi, and M.E. Rezvani Association of exon 9 but not intron 8 VDR polymorphisms with occult HBV infection in south-eastern Iranian patients J Gastroenterol Hepatol 25 2010 90 93
71. B. Halmos, F. Szalay, T. Cserniczky, E. Nemesanszky, P. Lakatos, and S. Barlage Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population Dig Dis Sci 45 2000 1091 1095
72. A. Tanaka, S. Nezu, S. Uegaki, K. Kikuchi, A. Shibuya, and H. Miyakawa Vitamin D receptor polymorphisms are associated with increased susceptibility to primary biliary cirrhosis in Japanese and Italian populations J Hepatol 50 2009 1202 1209
73. A. Vogel, C.P. Strassburg, and M.P. Manns Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis Hepatology 35 2002 126 131
74. D. Bitetto, A. Cussigh, E. Fornasiere, S. Cmet, E. Fontanini, and E. Bignulin Recipient vitamin D receptor BsmI-TaqI G-T/G-T diplotype predicts acute cellular rejection in liver transplanted patients Hepatology 54 2011 S638A
75. M.F. McDermott, A. Ramachandran, B.W. Ogunkolade, E. Aganna, D. Curtis, and B.J. Boucher Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians Diabetologia 40 1997 971 975
76. S. Roy, A. Frodsham, B. Saha, S.K. Hazra, C.G. Mascie-Taylor, and A.V. Hill Association of vitamin D receptor genotype with leprosy type J Infect Dis 179 1999 187 191
77. J.D. Simmons, C. Mullighan, K.I. Welsh, and D.P. Jewell Vitamin D receptor gene polymorphism: association with Crohn's disease susceptibility Gut 47 2000 211 214
78. R.J. Wilkinson, M. Llewelyn, Z. Toossi, P. Patel, G. Pasvol, and A. Lalvani Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study Lancet 355 2000 618 621
79. B.S. Park, J.S. Park, D.Y. Lee, J.I. Youn, and I.G. Kim Vitamin D receptor polymorphism is associated with psoriasis J Invest Dermatol 112 1999 113 116
80. T. Fukazawa, I. Yabe, S. Kikuchi, H. Sasaki, T. Hamada, and K. Miyasaka Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese J Neurol Sci 166 1999 47 52
81. Y. Ban, M. Taniyama, and Y. Ban Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population J Clin Endocrinol Metab 85 2000 4639 4643
82. M.T. Cantorna, Y. Zhu, M. Froicu, and A. Wittke Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system Am J Clin Nutr 80 2004 1717S 1720S
83. A.L. Ponsonby, A. McMichael, and I. van der Mei Ultraviolet radiation and autoimmune disease: insights from epidemiological research Toxicology 181-182 2002 71 78
84. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA 296 2006 2832 2838
85. K.L. Munger, S.M. Zhang, E. O'Reilly, M.A. Hernán, M.J. Olek, and W.C. Willett Vitamin D intake and incidence of multiple sclerosis Neurology 62 2004 60 65
86. E. Hyppönen, E. Läärä, A. Reunanen, M.R. Järvelin, and S.M. Virtanen Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study Lancet 358 2001 1500 1503
87. D.D. Bikle Vitamin D and the immune system: role in protection against bacterial infection Curr Opin Nephrol Hypertens 17 2008 348 352
88. S. Adams, O.P. Sharma, M.A. Gacad, and F.R. Singer Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis J Clin Invest 72 1983 1856 1860
89. F. Baeke, H. Korf, L. Overbergh, E. van Etten, A. Verstuyf, and C. Gysemans Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system J Steroid Biochem Mol Biol 121 2010 221 227
90. H. Sigmundsdottir, J. Pan, G.F. Debes, C. Alt, A. Habtezion, and D. Soler DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27 Nat Immunol 8 2007 285 293
91. R. Medzhitov Recognition of microorganisms and activation of the immune response Nature 449 2007 819 826
92. A. Ustianowski, R. Shaffer, S. Collin, R.J. Wilkinson, and R.N. Davidson Prevalence and associations of vitamin D deficiency in foreign-born persons with tuberculosis in London J Infect 50 2005 432 437
93. K.E. Nnoaham, and A. Clarke Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis Int J Epidemiol 37 2008 113 119
94. K.B. Gibney, L. MacGregor, K. Leder, J. Torresi, C. Marshall, and P.R. Ebeling Vitamin D deficiency is associated with tuberculosis and latent tuberculosis infection in immigrants from sub-Saharan Africa Clin Infect Dis 46 2008 443 446
95. P.T. Liu, S. Stenger, H. Li, L. Wenzel, B.H. Tan, and S.R. Krutzik Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 311 2006 1770 1773
96. R.F. Chun, A.L. Lauridsen, L. Suon, L.A. Zella, J.W. Pike, and R.L. Modlin Vitamin D-binding protein directs monocyte response to 25-hydroxy- and 1,25-dihydroxyvitamin D J Clin Endocrinol Metab 95 2010 3368 3376
97. A.L. Lauridsen, P. Vestergaard, A.P. Hermann, C. Brot, L. Heickendorff, and L. Mosekilde Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women Calcif Tissue Int 77 2005 15 22
98. S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E.J. Mutschelknauss, and D. Flesch-Janys The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status Cancer Epidemiol Biomarkers Prev 17 2008 1339 1343
99. A.R. Martineau, A.C. Leandro, S.T. Anderson, S.M. Newton, K.A. Wilkinson, and M.P. Nicol Association between Gc genotype and suspectibility to TB is dependent on vitamin D status Eur Respir J 35 2010 1106 1112
100. 3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomized controlled trial Lancet 377 2011 242 250
101. A. Mencin, J. Kluwe, and R.F. Schwabe Toll-like receptors as targets in chronic liver disease Gut 58 2009 704 720
102. H. Fukui, B. Brauner, J.C. Bode, and C. Bode Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay J Hepatol 12 1991 162 169
103. A. Parlesak, C. Schäfer, T. Schütz, J.C. Bode, and C. Bode Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease J Hepatol 32 2000 742 747
104. P.D. Cani, J. Amar, M.A. Iglesias, M. Poggi, C. Knauf, and D. Bastelica Metabolic endotoxemia initiates obesity and insulin resistance Diabetes 56 2007 1761 1772
105. G. Baffy Kupffer cells in non-alcoholic fatty liver disease: the emerging view J Hepatol 51 2009 212 223
106. J. Guo, and S.L. Friedman Toll-like receptor 4 signaling in liver injury and hepatic fibrogenesis Fibrogenesis Tissue Repair 3 2010 21
107. K. Sadeghi, B. Wessner, U. Laggner, M. Ploder, D. Tamandl, and J. Friedl Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns Eur J Immunol 36 2006 361 370
108. J.E. Do, S.Y. Kwon, S. Park, and E.S. Lee Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's disease Rheumatology (Oxford) 47 2008 840 848
109. G. Murillo, V. Nagpal, N. Tiwari, R.V. Benya, and R.G. Mehta Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer J Steroid Biochem Mol Biol 121 2010 403 407
110. L.J. Dickie, L.D. Church, L.R. Coulthard, R.J. Mathews, P. Emery, and M.F. McDermott Vitamin D3 down-regulates intracellular Toll-like receptor 9-induced IL-6 production in human monocytes Rheumatology (Oxford) 49 2010 1466 1471
111. L. Li, L. Chen, L. Hu, Y. Liu, H.Y. Sun, and J. Tang Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice Hepatology 54 2011 1620 1630
112. K. Miura, E. Seki, H. Ohnishi, and D.A. Brenner Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease Gastroenterol Res Pract 2010 362847
113. M.D. Berzsenyi, S.K. Roberts, S. Preiss, D.J. Woollard, M.R. Beard, and N.A. Skinner Hepatic TLR2 & TLR4 expression correlates with hepatic inflammation and TNF-α in HCV & HCV/HIV infection J Viral Hepat 18 2011 852 860
114. S. Yu, and M.T. Cantorna The vitamin D receptor is required for iNKT cell development Proc Natl Acad Sci U S A 105 2008 5207 5212
115. 3 enhances NK susceptibility of human melanoma cells via Hsp60-mediated FAS expression Eur J Immunol 40 2011 2937 2946
116. M. Hewison Vitamin D and immune function: an overview Proc Nutr Soc 71 2012 50 61
117. M.R. von Essen, M. Kongsbak, P. Schjerling, K. Olgaard, N. Odum, and C. Geisler Vitamin D controls T cell antigen receptor signaling and activation of human T cells Nature Immunol 11 2010 344 350
118. J.M. Lemire, D.C. Archer, L. Beck, and H.L. Spiegelberg Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions J Nutr 125 1995 1704S 1708S
119. A. Boonstra, F.J. Barrat, C. Crain, V.L. Heath, H.F. Savelkoul, and A. O'Garra 1α,25-dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells J Immunol 167 2001 4974 4980
120. G. Penna, and L. Adorini 1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation J Immunol 164 2000 2405 2411
121. C. Daniel, N.A. Sartory, N. Zahn, H.H. Radeke, and J.M. Stein Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile J Pharmacol Exp Ther 324 2008 23 33
122. D. D'Ambrosio, M. Cippitelli, M.G. Cocciolo, D. Mazzeo, P. Di Lucia, and R. Lang Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene J Clin Invest 101 1998 252 262
123. J. Smolders, P. Menheere, M. Thewissen, E. Peelen, J.W. Tervaert, and R. Hupperts Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis J Steroid Biochem Mol Biol 121 2010 243 246
124. 3 target genes J Steroid Biochem Mol Biol 121 2010 142 145
125. D. Bitetto, C. Fabris, E. Falleti, E. Fornasiere, E. Fumolo, and E. Fontanini Vitamin D and the risk of acute allograft rejection following human liver transplantation Liver Int 30 2010 417 422
126. H. Shirakawa, A. Matsumoto, S. Joshita, M. Komatsu, N. Tanaka, and T. Umemura Pretreatment prediction of virological response to peginterferon plus ribavirin therapy in chronic hepatitis C patients using viral and host factors Hepatology 48 2008 1753 1760
127. G. Livs hits, D. Karasik, and M.J. Seibel Statistical genetic analysis of plasma levels of vitamin D: familial study Ann Hum Genet 63 1999 429 439
128. M.K. Shea, E.J. Benjamin, J. Dupuis, J.M. Massaro, P.F. Jacques, and R.B. D'Agostino Sr. Genetic and non-genetic correlates of vitamins K and D Eur J Clin Nutr 63 2009 458 464
129. D. Hunter, M. De Lange, H. Snieder, A.J. MacGregor, R. Swaminathan, and R.V. Thakker Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation J Bone Miner Res 16 2001 371 378
130. T.J. Wang, F. Zhang, J.B. Richards, B. Kestenbaum, J.B. van Meurs, and D. Berry Common genetic determinants of vitamin D insufficiency: a genome-wide association study Lancet 376 2010 180 188
131. J. Ahn, K. Yu, R. Stolzenberg-Solomon, K.C. Simon, M.L. McCullough, and L. Gallicchio Genome-wide association study of circulating vitamin D levels Hum Mol Gen 19 2010 2739 2745
132. L. Fu, F. Yun, M. Oczak, B.Y. Wong, R. Vieth, and D.E. Cole Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation Clin Biochem 42 2009 1174 1177
133. R.F. Chun, B.E. Peercy, J.S. Adams, and M. Hewison Vitamin D binding protein and monocyte response to 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D: analysis by mathematical modeling PLoS One 7 2012 e30773
134. L. Chishimba, D.R. Thickett, R.A. Stockley, and A.M. Wood The vitamin D axis in the lung: a key role for vitamin D-binding protein Thorax 65 2010 456 462
135. L. Yin, N. Grandi, E. Raum, U. Haug, V. Arndt, and H. Brenner Meta-analysis: serum vitamin D and colorectal adenoma risk Prev Med 53 2011 10 16
136. D. Feskanich, J. Ma, C.S. Fuchs, G.J. Kirkner, S.E. Hankinson, and B.W. Hollis Plasma vitamin D metabolites and risk of colorectal cancer in women Cancer Epidemiol Biomarkers Prev 13 2004 1502 1508
137. E.D. Gorham, C.F. Garland, F.C. Garland, W.B. Grant, S.B. Mohr, and M. Lipkin Optimal vitamin D status for colorectal cancer prevention Am J Prev Med 32 2007 210 216
138. L. Yin, N. Grandi, E. Raum, U. Haug, V. Arndt, and H. Brenner Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk Aliment Pharmacol Ther 30 2009 113 125
139. E. Giovannucci Epidemiology of vitamin D and colorectal cancer: casual or causal link? J Steroid Biochem Mol Biol 121 2010 349 354
140. C.F. Garland, F.C. Garland, E.D. Gorham, M. Lipkin, H. Newmark, and S.B. Mohr The role of vitamin D in cancer prevention Am J Public Health 96 2006 252 261
141. S. Abbas, J. Linseisen, T. Slanger, S. Kropp, E.J. Mutschelknauss, and D. Flesch-Janys Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer - results of a large case-control study Carcinogenesis 29 2008 93 99
142. L. Yin, N. Grandi, E. Raum, U. Haug, V. Arndt, and H. Brenner Meta-analysis: serum vitamin D and breast cancer risk Eur J Cancer 46 2010 2196 2205
143. M.H. Ahonen, L. Tenkanen, L. Teppo, M. Hakama, and P. Tuohimaa Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland) Cancer Causes Control 11 2000 847 852
144. J. Ahn, D. Albanes, S.I. Berndt, U. Peters, N. Chatterjee, and N.D. Freedman Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk Carcinogenesis 30 2009 769 776
145. E.T. Chang, K.E. Smedby, H. Hjalgrim, A. Porwit-MacDonald, G. Roos, and B. Glimelius Family history of hematopoietic malignancy and risk of lymphoma J Natl Cancer Inst 97 2005 1466 1474
146. M. Touvier, D.S. Chan, R. Lau, D. Aune, R. Vieira, and D.C. Greenwood Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk Cancer Epidemiol Biomarkers Prev 20 2011 1003 1016
147. G. Lurie, L.R. Wilkens, P.J. Thompson, M.E. Carney, R.T. Palmieri, and P.D. Pharaoh Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium Int J Cancer 128 2011 936 943
148. K. Köstner, N. Denzer, C.S. Müller, R. Klein, W. Tilgen, and J. Reichrath The relevance of vitamin D receptor (VDR) gene polymorphisms for cancer: a review of the literature Anticancer Res 29 2009 3511 3536